OPKO Health Analyst Price Targets - Benzinga

OPKO Health Inc

OPKNASDAQ

Trade with Public

Trade with Public

$1.64

0.031.86%

At close: Sep 4, 5:00 PM EST

$1.62

-0.0182-1.11%

After Hours: Sep 4, 7:27 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

OPKO Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for OPKO Health (OPK).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

2Buy

3Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$3Upside to Avg. PT+63.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 29, 2026	Barrington Research	Michael Petusky	Downgrade	Outperform→Market Perform	—
Mar 2, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$2→$2
Nov 20, 2025	JP Morgan	Brian Cheng	Initiate	Neutral	—
Oct 31, 2025	Jefferies	Maury Raycroft	Downgrade	Buy→Hold	$2→$2
Oct 30, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$2
May 1, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$2
Apr 25, 2025	JP Morgan	Eric Joseph	Initiate	Neutral	—
Apr 7, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$3
Mar 19, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$3
Mar 12, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$3
Mar 12, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$2
Mar 3, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$3
Feb 28, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$2
Jan 8, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$3
Nov 8, 2024	Barrington Research	Michael Petusky	Maintained	Outperform	$2
Sep 26, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$3
Sep 20, 2024	Barrington Research	Michael Petusky	Maintained	Outperform	$2
Sep 17, 2024	Piper Sandler	Edward Tenthoff	Maintained	Overweight	$3
Sep 17, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$3
Aug 8, 2024	Barrington Research	Michael Petusky	PT Raise	Outperform	$2→$2

More with Benzinga EdgeGet Access

Analyst Ratings News

This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. PRPL, OPK, BF.B, MELI, RPD stocks downgraded.

Avi Kapoor

PRO
Barrington Research Downgrades OPKO Health to Market Perform

Barrington Research analyst Michael Petusky downgrades OPKO Health (NASDAQ:OPK) from Outperform to Market Perform.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on OPKO Health, Lowers Price Target to $1.5

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and lowers the price target from $2.25 to $1.5.

Benzinga Newsdesk

PRO
JP Morgan Initiates Coverage On OPKO Health with Neutral Rating

JP Morgan analyst Brian Cheng initiates coverage on OPKO Health (NASDAQ:OPK) with a Neutral rating.

Benzinga Newsdesk

PRO
Jefferies Downgrades OPKO Health to Hold, Lowers Price Target to $1.6

Jefferies analyst Maury Raycroft downgrades OPKO Health (NASDAQ:OPK) from Buy to Hold and lowers the price target from $2 to $1.6.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $2.25 price target.

Benzinga Newsdesk